Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MRAI
Upturn stock ratingUpturn stock rating

Marpai Inc (MRAI)

Upturn stock ratingUpturn stock rating
$1.23
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/12/2025: MRAI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6

1 Year Target Price $6

Analysts Price Target For last 52 week
$6 Target price
52w Low $0.43
Current$1.23
52w High $1.68

Analysis of Past Performance

Type Stock
Historic Profit -59.68%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 21.24M USD
Price to earnings Ratio -
1Y Target Price 6
Price to earnings Ratio -
1Y Target Price 6
Volume (30-day avg) 1
Beta 4.64
52 Weeks Range 0.43 - 1.68
Updated Date 09/14/2025
52 Weeks Range 0.43 - 1.68
Updated Date 09/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.92

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -51.35%
Operating Margin (TTM) -77.47%

Management Effectiveness

Return on Assets (TTM) -40.88%
Return on Equity (TTM) -1359.59%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 24461141
Price to Sales(TTM) 0.9
Enterprise Value 24461141
Price to Sales(TTM) 0.9
Enterprise Value to Revenue 0.7
Enterprise Value to EBITDA -0.89
Shares Outstanding 17270000
Shares Floating 9053125
Shares Outstanding 17270000
Shares Floating 9053125
Percent Insiders 49.81
Percent Institutions 10.8

ai summary icon Upturn AI SWOT

Marpai Inc

stock logo

Company Overview

overview logo History and Background

Marpai, Inc. (MRAI) is a technology company focused on developing artificial intelligence (AI) solutions for third-party administrators in the healthcare industry. While a relatively newer company, its formation and initial success is based on integrating technology within healthcare benefits.

business area logo Core Business Areas

  • Third-Party Administration (TPA) Services: Marpai provides TPA services using AI to manage healthcare claims, process payments, and provide data analytics.
  • AI-Powered Platform: Their core offering is an AI platform to optimize healthcare spending and improve health outcomes. This includes claim processing, care navigation, and cost containment.

leadership logo Leadership and Structure

The leadership team consists of experienced executives in technology and healthcare. Details on specific individuals and the precise organizational structure can be found on Marpai's investor relations website or public filings.

Top Products and Market Share

overview logo Key Offerings

  • Marpai Rx Navigator: AI-powered pharmacy benefits solution helping optimize drug costs. Market share data for this specific product is not readily available. Competitors: CVS Caremark, Express Scripts, OptumRx.
  • Smart Claim Negotiation: AI that negotiates claims to reduce costs. Precise market share unavailable. Competitors: Accolade, Quantum Health.

Market Dynamics

industry overview logo Industry Overview

The healthcare benefits administration industry is large and growing, driven by rising healthcare costs and increasing demand for technology-driven solutions. AI adoption is still in early stages but accelerating.

Positioning

Marpai positions itself as a technology disruptor in the TPA space, offering AI-driven solutions to improve efficiency and reduce costs. Their competitive advantage lies in its AI platform.

Total Addressable Market (TAM)

The TAM for AI in healthcare benefits administration is estimated to be in the tens of billions of dollars. Marpai is positioned to capture a share of this market through its innovative AI platform.

Upturn SWOT Analysis

Strengths

  • Proprietary AI technology
  • Focus on cost containment
  • Scalable platform
  • Experienced leadership team

Weaknesses

  • Limited operating history
  • Small market share compared to large competitors
  • Dependence on key personnel
  • High operating costs

Opportunities

  • Growing demand for AI in healthcare
  • Expansion into new markets
  • Strategic partnerships
  • Acquisition opportunities

Threats

  • Competition from established players
  • Rapid technological changes
  • Regulatory changes
  • Economic downturn

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • CI
  • HUM
  • THC

Competitive Landscape

Marpai faces intense competition from large, established players. Its AI technology and focus on cost containment provide a competitive edge, but significant challenges remain in gaining market share.

Growth Trajectory and Initiatives

Historical Growth: Marpai is experiencing growth, but it has had fluctuating revenue results.

Future Projections: Analyst projections for Marpai's future growth are not readily available and may vary depending on the source. Check analyst estimates.

Recent Initiatives: Focus on platform improvement, strategic partnerships, and sales and marketing initiatives.

Summary

Marpai is a technology company attempting to disrupt the healthcare benefits administration industry with its AI-driven solutions. While it boasts a unique AI platform and focuses on cost containment, it is constrained by its limited history and relatively small market share. The company must effectively compete with larger, more established players and continue to innovate to solidify its position in the market, however its limited capital makes this exceedingly difficult. Market perception is also an issue with the stock regularly targeted by short sellers.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC filings (10-K, 10-Q)
  • Company website
  • Industry reports
  • Analyst reports (if available)

Disclaimers:

This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change. Conduct thorough research before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Marpai Inc

Exchange NASDAQ
Headquaters Tampa, FL, United States
IPO Launch date 2021-10-27
CEO & Director Mr. Damien Francis Lamendola
Sector Healthcare
Industry Healthcare Plans
Full time employees 117
Full time employees 117

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.